HEC585
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HEC585, covering 2026-04-21 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients [Phase 2]